[1] GARGIULO P,DELLA P C,BERARDI S,et al.Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated endometrial cancers:new candidates for checkpoint blockade immunotherapy?[J].Cancer Treat Rev,2016,48(1):61-68.
[2] 张楠,郑虹.子宫内膜癌的分子标记物在早期诊断中的作用[J].实用妇产科杂志,2015,31(7):493-495.
[3] OlIVETO S,MANCINO M,MANFRINI N,et al.Role of microRNAs in translation regulation and cancer[J].World J Biol Chem,2017,8(1):45-56.
[4] MELNIK B C.MiR-21:an environmental driver of malignant melanoma?[J].J Transl Med,2015,13(1):202.
[5] DONG J,ZHANG Z,GU T,et al.The role of microRNA-21 in predicting brain metastases from non-small cell lung cancer[J].Onco Targets Ther,2017,10:185-194.
[6] TSUJITA Y,MITSUI-SEKINAKA K,IMAI K,et al.Phosphatase and tensin homolog(PTEN) mutation can cause activated phosphatidylinositol 3-kinase delta syndrome-like immunodeficiency[J].J Allergy Clin Immunol,2016,138(6):1672-1680.
[7] PAPAGIANNAKOPOULOS T,SHAPIRO A,KOSIK K S.MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells[J].Cancer Res,2008,68(19):8164-8172.
[8] MERCADO-PIMENTE L,ONYEAGUCHA B C,LI Q,et al.The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells[J].FEBS Lett,2015,589(18):2388-2393.
[9] DIRICAN E,AKKIPRIK M.Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer[J].Tumour Biol,2017,39(3):1-16.
[10] YADAV P,MIRZA M,NANDI K,et al.Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients[J].Tumour Biol,2016,37(11):15275-15282.
[11] ASANGANI I A,RASHEED S A,NIKOLOVA D A,et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion,intravasation and metastasis in colorectal cancer[J].Oncogene,2008,27(15):2128-2136. |